GO:0015986 proton motive force-driven ATP synthesis: Chemiosmotic Energy Conversion, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015986 describes the biological process in which ATP is synthesized using the proton-motive force (PMF) generated by proton translocation across a membrane.
• The process is synonymous with chemiosmosis and ATP synthesis coupled to proton transport, and is catalyzed by rotating proton-pumping ATPases such as F-type and V/A-type ATPases.
• PMF-driven ATP synthesis is not limited to mitochondria and chloroplasts; it also powers bacterial drug extrusion, CO formation in methanogens, and flagellar type-III secretion [1,4,8].
• In multidrug-resistant bacteria, PMF-driven and ATP-dependent efflux systems cooperate to export toxic compounds, making this process a target for resistance-breaking strategies [1,2,5].
• Key experimental approaches include membrane-vesicle transport assays, ATP synthesis measurements, cryo-EM, and genetic knockout or point mutation of ATPase subunits [6,8].
• Dysregulation of PMF-driven ATP synthesis is linked to mitochondrial disease, cancer metabolism, and bacterial persistence, offering multiple translational research avenues.
Description
GO:0015986, proton motive force-driven ATP synthesis, is the biological process in which the chemical reactions and pathways leading to ATP formation are driven by the transport of protons across a membrane to generate an electrochemical gradient, also called the proton-motive force. This process is the central mechanism of chemiosmotic energy conversion and is carried out by rotating proton-pumping ATPases, including F-type ATP synthases and related V/A-type enzymes. The term captures both the generation of the proton gradient and its subsequent use for ATP synthesis, making it a cornerstone of cellular bioenergetics. Beyond canonical mitochondrial and chloroplast ATP production, PMF-driven ATP synthesis is also observed in diverse bacterial systems, where it supports drug extrusion, metabolic transformations, and flagellar secretion [1,4,8]. For example, in multidrug-resistant Lactococcus lactis, PMF-driven drug extrusion systems operate alongside ATP-dependent transporters to confer resistance. Similarly, in methanogenic bacteria, the proton-motive force drives the formation of CO from CO2 and H2, illustrating the broad metabolic reach of this process. In Mycobacterium smegmatis, isoniazid accumulation is modulated by both PMF-driven and ATP-dependent extrusion systems, linking this GO term to antibiotic susceptibility. The mechanistic basis of PMF-driven ATP synthesis has been illuminated by structural and biochemical studies of rotating proton-pumping ATPases, which couple proton translocation to rotary catalysis. More recently, the FliI ATPase has been shown to couple ATP hydrolysis to substrate switching in bacterial flagellar type-III secretion, highlighting additional roles for PMF-related energetics in secretion systems. Because of its central role in energy metabolism and its involvement in bacterial resistance and secretion, GO:0015986 is a high-value target for basic and translational research [2,6].
proton motive force-driven ATP synthesis At A Glance
| GO ID | GO:0015986 |
|---|---|
| GO term | proton motive force-driven ATP synthesis |
| Ontology | biological_process |
| Synonym | ATP synthesis coupled proton transport; chemiosmosis |
| Major function | Synthesis of ATP using the proton-motive force generated by proton translocation across a membrane |
| Key enzymes | Rotating proton-pumping ATPases, including F-type and V/A-type ATP synthases |
| Cellular context | Mitochondrial inner membrane, chloroplast thylakoid membrane, bacterial plasma membrane |
| Related processes | Proton transport, oxidative phosphorylation, photophosphorylation, multidrug efflux [1,2,6] |
| Representative organisms | Bacteria, archaea, mitochondria, chloroplasts [1,4,6] |
What Is GO:0015986?
In simple terms, GO:0015986 describes how cells make ATP by using a proton gradient across a membrane. The official definition is: the chemical reactions and pathways resulting in the formation of ATP driven by transport of protons across a membrane to generate an electrochemical gradient (proton-motive force). This process is also known as chemiosmosis or ATP synthesis coupled proton transport, and it is executed by molecular motors such as F-type ATP synthases that convert the energy stored in the proton gradient into the chemical energy of ATP.
Why Is proton motive force-driven ATP synthesis Important in Cell Biology?
GO:0015986 is fundamental to life because it is the principal route by which cells convert electrochemical energy into ATP, the universal energy currency. In bacteria, PMF-driven ATP synthesis and related PMF-driven transport systems contribute to multidrug resistance, metabolic versatility, and virulence-associated secretion [1,2,5,8]. In eukaryotes, defects in the machinery that carries out this process are linked to mitochondrial disorders and altered cancer metabolism. Understanding the molecular details of PMF-driven ATP synthesis therefore has broad implications for antimicrobial drug discovery, metabolic engineering, and the treatment of energy-metabolism diseases [2,6].
• Provides the mechanistic basis for chemiosmotic ATP production in mitochondria, chloroplasts, and bacteria.
• Enables bacterial multidrug resistance through PMF-driven drug extrusion systems that cooperate with ATP-dependent transporters [1,2].
• Modulates antibiotic accumulation, as shown for isoniazid in Mycobacterium smegmatis.
• Supports non-canonical metabolic reactions such as CO formation from CO2 and H2 in methanogens.
• Couples energetics to bacterial flagellar type-III secretion via the FliI ATPase.
• Serves as a target for inhibitors that disrupt proton gradients or ATPase rotary catalysis.
• Is relevant to mitochondrial disease and cancer metabolism through altered ATP synthase function.
• Offers a model system for studying rotary molecular motors and energy coupling.
• Underpins biotechnological applications that require efficient ATP supply in engineered microbes.
• Connects to broader questions in evolutionary biology about the origin of chemiosmosis.
What Happens During proton motive force-driven ATP synthesis?
Generation of the proton-motive force
In simple terms: First, protons are pumped across a membrane to create a difference in proton concentration and charge.
The proton-motive force is established when proton translocation across a membrane creates an electrochemical gradient. In mitochondria and bacteria, this is often driven by respiratory chain complexes, while in chloroplasts it is driven by photosynthetic electron transport. The resulting gradient stores energy that can be used for ATP synthesis. In some bacterial systems, PMF-driven drug extrusion systems also depend on this gradient, illustrating its central role in membrane energetics [1,2].
Proton translocation through the ATP synthase
In simple terms: Protons then flow back through a molecular motor, turning it like a turbine.
Rotating proton-pumping ATPases, such as F-type ATP synthases, allow protons to move down their electrochemical gradient through a membrane-embedded rotor. This proton flow induces rotation of the c-ring and central stalk, coupling proton translocation to mechanical rotation. Structural and biochemical studies have revealed the detailed mechanism of this rotary catalysis.
Rotary catalysis and ATP formation
In simple terms: The turning motor changes the shape of the catalytic sites so they can make ATP.
Rotation of the central stalk drives conformational changes in the catalytic headpiece, promoting binding of ADP and inorganic phosphate, formation of ATP, and release of the product. This rotary mechanism is a hallmark of F-type and related ATP synthases. The process is reversible, and under certain conditions the same enzyme can hydrolyze ATP to pump protons.
Coupling to cellular processes
In simple terms: The ATP made this way powers many other jobs in the cell, including transport and secretion.
ATP produced by PMF-driven synthesis fuels diverse cellular activities. In bacteria, PMF-driven and ATP-dependent extrusion systems work together to export drugs, contributing to multidrug resistance [1,2,5]. In flagellar type-III secretion, the FliI ATPase couples ATP hydrolysis to substrate switching, linking energetics to protein export. In methanogens, the proton-motive force drives CO formation from CO2 and H2, demonstrating metabolic coupling.
Regulation and adaptation
In simple terms: Cells can adjust how much ATP they make depending on their needs and environment.
The efficiency of PMF-driven ATP synthesis can be modulated by changes in membrane potential, proton gradient, and expression or activity of ATP synthase subunits. In bacteria, adaptation to antibiotics can involve upregulation of PMF-driven efflux systems [1,5]. The interplay between PMF-driven and ATP-dependent processes allows flexible responses to metabolic and environmental challenges.
Key Genes Involved in GO:0015986 proton motive force-driven ATP synthesis
The following genes and proteins are central to proton motive force-driven ATP synthesis and its associated cellular functions.
| Gene | Major Role | Research Relevance |
|---|---|---|
| atpB | F-type ATP synthase subunit | Catalytic core of PMF-driven ATP synthesis; target for mechanistic and structural studies |
| atpE | F-type ATP synthase subunit | Proton translocation and rotary catalysis; studied in bacteria and mitochondria |
| atpA | F-type ATP synthase subunit | Catalytic site formation; relevant to ATP synthesis efficiency |
| atpD | F-type ATP synthase subunit | Nucleotide binding; used in mutagenesis studies |
| atpC | F-type ATP synthase subunit | Regulation of rotary catalysis |
| atpF | F-type ATP synthase subunit | Membrane rotor component; affects proton gradient utilization |
| atpH | F-type ATP synthase subunit | Stator function; important for enzyme assembly |
| fliI | Flagellar type-III secretion ATPase | Couples ATP hydrolysis to substrate switching; model for PMF-related energetics |
| lldP | PMF-driven drug transporter | Multidrug resistance in Lactococcus lactis; links PMF to efflux |
| lmrP | PMF-driven drug transporter | ATP-dependent and PMF-driven extrusion; studied in multidrug resistance |
| mmpL | RND transporter family member | Anaerobic-associated multidrug efflux; structural basis for PMF-driven transport |
| pma1 | Plasma membrane H+-ATPase | Generates proton gradient in fungi and plants; model for PMF generation |
| cox1 | Cytochrome c oxidase subunit | Respiratory chain component that contributes to PMF |
| ndh1 | NADH dehydrogenase subunit | Proton pumping in respiratory chain; supports PMF |
| atpG | F-type ATP synthase subunit | Stator/rotor interface; relevant to enzyme stability |
| ppa | Inorganic pyrophosphatase | Affects energy balance and ATP synthesis indirectly |
| mrp | Multiple resistance and pH regulation | PMF-related antiporter; studied in bacterial stress responses |
How Is proton motive force-driven ATP synthesis Regulated?
The process of proton motive force-driven ATP synthesis is regulated at multiple levels. The magnitude of the proton-motive force itself depends on the balance between proton pumping and proton leak, which is influenced by respiratory chain activity and membrane integrity. In bacteria, expression of PMF-driven efflux systems can be induced by sublethal antibiotic exposure, as seen in multidrug-resistant Lactococcus lactis and Mycobacterium smegmatis [1,5]. The activity of rotating ATPases can also be modulated by subunit interactions and by the availability of substrates such as ADP and inorganic phosphate. Additionally, the coupling between PMF-driven and ATP-dependent processes allows cells to prioritize energy allocation under stress. In flagellar type-III secretion, the FliI ATPase regulates substrate switching, providing an example of how ATP hydrolysis and PMF-related energetics are coordinated.
proton motive force-driven ATP synthesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| atpB | Mitochondrial ATP synthase deficiency | Knockout or point-mutation in cell lines; ATP synthesis assays |
| atpE | Mitochondrial disease with proton leak | Knock-in of patient variants; membrane potential measurements |
| lldP | Multidrug resistance in Lactococcus lactis | Knockout and overexpression in bacterial strains; drug efflux assays |
| mmpL | Anaerobic-associated multidrug efflux | Structural and knockout studies in bacterial models |
| fliI | Flagellar secretion and virulence | Knockout in bacterial flagellar systems; secretion assays |
Mitochondrial disorders and ATP synthase dysfunction
Mutations in genes encoding F-type ATP synthase subunits can impair PMF-driven ATP synthesis, leading to mitochondrial diseases characterized by energy deficiency. Studies of rotating proton-pumping ATPases have provided mechanistic insight into how such mutations affect rotary catalysis and ATP production.
Multidrug resistance in bacterial infections
PMF-driven drug extrusion systems contribute to multidrug resistance in bacteria such as Lactococcus lactis and Mycobacterium smegmatis. These systems work alongside ATP-dependent transporters to reduce intracellular drug accumulation, complicating antibiotic treatment [1,2,5]. Structural studies of RND transporters have further revealed the molecular basis for PMF-driven efflux in anaerobic-associated bacteria.
Cancer metabolism and metabolic reprogramming
Altered ATP synthesis and mitochondrial function are hallmarks of cancer metabolism. Although direct evidence linking GO:0015986 to specific cancers is still emerging, the central role of ATP synthase in energy production makes it a subject of ongoing research.
Bacterial secretion and virulence
The FliI ATPase couples ATP hydrolysis to substrate switching in bacterial flagellar type-III secretion, a process important for motility and virulence. This connection highlights how PMF-related energetics can influence bacterial pathogenesis.
From proton motive force-driven ATP synthesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ATP synthase subunit X abolish PMF-driven ATP synthesis? | Knockout cell lines or bacterial strains with ATP synthesis assays |
| How does a patient-derived point mutation affect rotary catalysis? | Point-mutation knock-in models with biochemical and structural readouts |
| Can a tagged ATP synthase subunit be used to track assembly? | Tagged knock-in (e.g., GFP or FLAG) followed by imaging and proteomics |
| Does overexpression of a PMF-driven transporter increase drug resistance? | Overexpression models in bacteria with minimal inhibitory concentration tests [1,5] |
| What is the role of FliI in substrate switching? | Knockout and point-mutation models in flagellar secretion systems |
| Can PMF-driven ATP synthesis be redirected for metabolic engineering? | Engineered microbial strains with modified ATP synthase expression |
How to Study the proton motive force-driven ATP synthesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Membrane vesicle ATP synthesis assay | ATP production driven by proton gradient | Functional characterization of ATP synthases |
| Cryo-EM | Three-dimensional structure of ATP synthase or transporter | Mechanistic studies of rotary catalysis and efflux [3,6] |
| Knockout models | Loss-of-function effects on PMF-driven processes | Target validation in bacteria or cell lines |
| Point-mutation knock-in | Effect of specific variants on ATP synthesis | Disease variant modeling |
| Drug efflux assays | Intracellular drug accumulation | Multidrug resistance studies [1,5] |
| Flagellar secretion assays | Substrate switching and secretion efficiency | Bacterial virulence research |
| Proteomics | Expression and assembly of ATP synthase subunits | Systems-level analysis of energy metabolism |
| Live-cell imaging | Membrane potential and ATP levels | Real-time monitoring of PMF-driven ATP synthesis |
Membrane vesicle and ATP synthesis assays
Membrane vesicles can be used to measure proton translocation and ATP synthesis directly. These assays allow researchers to quantify the proton-motive force and its coupling to ATP production, as demonstrated in studies of rotating proton-pumping ATPases.
Structural biology and cryo-EM
Cryo-electron microscopy and X-ray crystallography have revealed the architecture of F-type ATP synthases and RND transporters, providing mechanistic insights into PMF-driven processes [3,6].
Genetic knockout and point mutation
Knockout and point-mutation models are essential for dissecting the roles of specific subunits and transporters. For example, mutations in ATP synthase subunits can be introduced to test effects on rotary catalysis and ATP synthesis.
Drug efflux and resistance assays
PMF-driven drug extrusion can be measured using fluorescent dyes or radiolabeled drugs in bacterial strains. Such assays have been used to study multidrug resistance in Lactococcus lactis and Mycobacterium smegmatis [1,5].
How CRISPR Can Be Used to Study GO:0015986 proton motive force-driven ATP synthesis
Knockout
CRISPR knockout of genes encoding ATP synthase subunits or PMF-driven transporters can abolish or reduce PMF-driven ATP synthesis. Such models are used to test the requirement for specific subunits in ATP production and drug resistance.
Point Mutation
CRISPR point mutation allows introduction of disease-associated or mechanistic variants into ATP synthase genes. These models help determine how single amino acid changes affect rotary catalysis and proton translocation.
Knock-in
Knock-in of tagged or reporter constructs enables tracking of ATP synthase assembly and localization. Tagged knock-in models are valuable for imaging and proteomic studies of PMF-driven ATP synthesis.
Overexpression
CRISPR-mediated overexpression of PMF-driven transporters or ATP synthase subunits can be used to study gain-of-function phenotypes, such as increased drug resistance or enhanced ATP synthesis capacity [1,5].
How EDITGENE Supports proton motive force-driven ATP synthesis Research
Researchers studying proton motive force-driven ATP synthesis-related genes often need to determine whether a candidate gene is causally involved in ATP production, drug resistance, or related cellular processes. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for proton motive force-driven ATP synthesis research.
Frequently Asked Questions About proton motive force-driven ATP synthesis
What is GO:0015986?
GO:0015986 is the Gene Ontology term for proton motive force-driven ATP synthesis, the process of making ATP using a proton gradient across a membrane.
What genes are involved in proton motive force-driven ATP synthesis?
Key genes include ATP synthase subunits such as atpB, atpE, atpA, and atpD, as well as PMF-driven transporters like lldP and mmpL [1,6].
What is another name for proton motive force-driven ATP synthesis?
It is also known as chemiosmosis or ATP synthesis coupled proton transport.
How does the proton-motive force drive ATP synthesis?
Protons flow through a rotating ATP synthase, causing conformational changes that catalyze ATP formation from ADP and phosphate.
Is proton motive force-driven ATP synthesis only in mitochondria?
No, it also occurs in chloroplasts and bacteria, where it supports diverse processes including drug efflux and secretion [1,4,6].
How is PMF-driven ATP synthesis linked to multidrug resistance?
PMF-driven efflux systems export drugs from bacterial cells, contributing to resistance alongside ATP-dependent transporters [1,2,5].
What experimental methods study PMF-driven ATP synthesis?
Common methods include membrane vesicle ATP synthesis assays, cryo-EM, knockout models, and drug efflux assays.
Can CRISPR be used to study PMF-driven ATP synthesis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools for dissecting this process.
What diseases are associated with defects in PMF-driven ATP synthesis?
Mitochondrial disorders and bacterial multidrug resistance are prominent examples [1,6].
What is the role of FliI in PMF-related processes?
FliI is an ATPase that couples ATP hydrolysis to substrate switching in bacterial flagellar type-III secretion.
Conclusion
GO:0015986, proton motive force-driven ATP synthesis, is a central biological process that converts electrochemical energy into ATP. Its mechanisms span mitochondrial, chloroplast, and bacterial systems, with important roles in drug resistance, secretion, and metabolism [1,4,6,8]. Understanding this process offers opportunities for therapeutic intervention and biotechnological innovation. EDITGENE provides the CRISPR tools needed to dissect the genes and pathways involved in PMF-driven ATP synthesis.
References
- 1. Bolhuis H et al.. 1994. Proton motive force-driven and ATP-dependent drug extrusion systems in multidrug-resistant Lactococcus lactis.. J Bacteriol 176(22):6957-64 PMID: 7961458
- 2. Mazurkiewicz P et al.. 2005. What do proton motive force driven multidrug resistance transporters have in common?. Curr Issues Mol Biol 7(1):7-21 PMID: 15580777
- 3. Lawrence R et al.. 2025. Molecular basis for multidrug efflux by an anaerobic-associated RND transporter.. Nat Commun 16(1):10601 PMID: 41339309
- 4. Bott M et al.. 1987. Proton-motive-force-driven formation of CO from CO2 and H2 in methanogenic bacteria.. Eur J Biochem 168(2):407-12 PMID: 2822415
- 5. Choudhuri BS et al.. 1999. Isoniazid accumulation in Mycobacterium smegmatis is modulated by proton motive force-driven and ATP-dependent extrusion systems.. Biochem Biophys Res Commun 256(3):682-4 PMID: 10080959
- 6. Nakanishi-Matsui M et al.. 2010. The mechanism of rotating proton pumping ATPases.. Biochim Biophys Acta 1797(8):1343-52 PMID: 20170625
- 8. Einenkel R et al.. 2026. The FliI ATPase couples ATP hydrolysis to substrate switching in bacterial flagellar type-III secretion.. mBio 17(1):e0235425 PMID: 41347794
